Pedersen and Maggie Fick COPENHAGEN (Reuters) -Shares in Wegovy maker Novo Nordisk fell further on Wednesday as analysts ...

Novo’s challenges from both a pharmaceutical giant in Lilly and the low-cost competition from compounded drugs sellers led to ...

Investing.com - Novo Nordisk (NYSE:NVO)’s weight-loss and diabetes drugs Wegovy and Ozempic could face increased pressure in the future, weighing on the Danish pharmaceutical group’s earnings, ...

Novo Nordisk's new CEO, Maziar Mike Doustdar, is tasked with revitalizing the company's flagging sales and addressing ...

Investors braced for the Federal Reserve's next interest rate decision and earnings from tech giants Microsoft and Meta.

Morgan Stanley raised its price targets across a basket of semiconductor names, citing “exceptional” strength in artificial intelligence demand from hyperscalers and consumer internet firms.

Securities on Tuesday downgraded United Parcel Service Inc (NYSE:UPS) shares to Neutral from Buy, flagging a clouded outlook and slow progress on cost-cutting initiatives.

Hit by rising medical care costs and squeezed by government changes, the health care conglomerate acknowledges “pricing and operational mistakes” affected its bottom line and has outlined steps to ...